Like you, we are 100% focused on the aorta, from the aortic root to the iliac arteries. We understand that no two aortas are alike. Whether it’s an off-the-shelf or custom-made product, our broad portfolio of diverse surgical, endovascular and hybrid solutions is designed to offer options as individualised as your patient’s anatomy.*

With our wide range of aortic products, Terumo Aortic enables you to find the best approach for each case — and each patient.

*Hybrid and surgical portfolio does not currently include custom configurations. Subject to local regulatory approval. Product availability subject to local regulatory approval. CAUTION - Investigational Device limited by Federal (or United States) law to investigational use. Not approved in the USA.



Terumo Aortic products are powered by technologies that help ensure that every product you use can be implanted or deployed safely.

Advanced Delivery

Terumo Aortic delivery systems use proprietary technology to reposition, deploy and facilitate the implant and overall procedure.

Knitting & Weaving

We utilise looms specially adapted to the needs of aortic repair textiles. Our unique Köper knitted structure features yarns arranged perpendicular to each other on the inner surface. This preserves all the advantages of a knitted material, such as superb handling, absence of fraying and also displays significantly reduced dilatation when compared to warp-knitted grafts.1,2

Sealant Technology

Sealed products feature a patented gelatin outer coating to assist the implantation process. Our Gelatin has been shown to have a low thrombogenicity.3

The gelatin technology is also an ideal sealant for bonding to the antibiotic rifampicin, which is used to minimise the occurrence of graft infection after implantation.†,4-6 Terumo Aortic have CE mark approval for both heparin and rifampicin bonding.†,7

Unlike other sealants, Terumo Aortic’s Gelatin is broken down by the body’s own natural means over a period of approximately 14 days. This process does not provoke a prolonged inflammatory response within the patient’s body.8

This sealant removal rate allows natural tissue ingrowth to occur within the structure of the graft thereby mimicking the body’s natural mechanisms.9

Please Note: The rifampicin loading procedure is subject to local regulatory approval and has not been approved in the United States of America, Canada or Singapore.


Walker D, et al. Novel structure for a polyester vascular prosthesis with improved mechanical properties. Society for Biomaterials. 1995.

Goëau-Brissonnière O, et al. Can knitting effect dilation of polyester bifurcated prosthesis? A randomised study with the use of helical computed tomographic scanning. Journal of Vascular Surgery. 2000;31:157-163.

3. P C Jenkinson Bsc, Phd. Gelseal Triaxial and Microvel Double Velour with Hemashield (Safepharm Report). Safepharm Laboratories Ltd.

O Goeau-Brissonniere, J Goldstone, E Keiffer, F Koskas, D Lew, A Nevelsteen, J C Pechere and G Peters. Rifampin Bonded Graft European Trial: (RBGET) Meeting. 1995.

Ashton TR, Cunningham JD, Patan D and Maini R. Antibiotic loading of vascular grafts. In: Proceedings of the 16th Annual Meeting of the Society for Biomaterials. Charleston, USA; 1990;13.

Strachan CJL, Newsom SWB, Ashton TR. The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg. 1991; 5:627-632. doi:

Rinsing of Gelatin Sealed Prostheses with Rifampicin and/or Heparin BSI EQ# 10020927. 1995.

Vohra R, Drury JK, Shapiro D, Shenkin A, Pollock JG. Sealed versus unsealed knitted Dacron® prosthesis: A comparison of the acute phase protein response. Annals of Vasc Surg. 1987;I:548-551. doi:

Robert Guidoin, Daniel Marceau, Tian Jian Rao, Martin King, Yahye Merhi, Paul-Emile Roy, Louisette Martin, and Marcellin Duval. In-Vitro and In-Vivo Characterization of an Impervious Polyester Arterial Prosthesis: The Gelseal Triaxial® Graft. Biomaterials. 1987; Vol 8 November.